GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Issuance of Debt

FBLG (FibroBiologics) Issuance of Debt : $0.57 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Issuance of Debt?

FibroBiologics's Issuance of Debt for the three months ended in Sep. 2024 was $0.00 Mil.

FibroBiologics's Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 was $0.57 Mil.

FibroBiologics Issuance of Debt Historical Data

The historical data trend for FibroBiologics's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Issuance of Debt Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Issuance of Debt
2.28 4.30 0.30

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - 0.57 - -

FibroBiologics Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.57 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FibroBiologics Issuance of Debt Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroBiologics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (NAS:FBLG) » Definitions » Issuance of Debt
Comparable Companies
ATRA GBIO KALA VICP VYNE ANVS INKT CELU CLGN BLUE VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
SG0:Germany
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
Website
https://www.fibrobiologics.com
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.